“Suswasthya”
- A Systemic Care Division
Deurali – Janta with a view to expand its product profile
as per the increasing product demand of the market (and as per the
Essential Drugs List of Nepalese National Formulatory) have introduced
‘Suwasthya Division’ as an expansion to its current
range of products. more ...
DJPL - Search
Search the DJPL contents
Production
The manufacturing plant at Kathmandu has seen
strategic and significant changes in the recent
years to produce highest quality products.
The production processes have been adopted
and validated not only to meet with WHO GMP
guidelines but also to meet the requirement
of other international regulatory agencies.
The highly sophisticated state-of-the-art
manufacturing plant at Dhapasi, Kathmandu
is operational to produce highest quality
products to meet the demanding market of the
present day.
Deurali-Janta
currently manufactures antibiotics & oral
solids (Tables/Capsules/Dry powders) as well
as liquid dosage forms, in it’s about
45,000 sq. ft. of Centrally Air Conditioned
facilities.
